• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number SP-101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erythema (1840); Inflammation (1932); Patient Problem/Medical Problem (2688)
Event Date 11/01/2017
Event Type  Injury  
Manufacturer Narrative
Event date: month and year only valid literature article.Doi: 10.26717/bjstr.2019.17.003040.Venasealtm cyanoacrylate glue rejection following endovenous ablation.Another new complication ps lew, yk tan: department of general surgery, changi general hospital, singapore tt chong and ty tang: department of vascular surgery, singapore general hospital, singapore.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the physician used a venaseal closure system to carry out a procedure in (b)(6) 2017.The right great saphenous vein (gsv) and small saphenous vein(gsv) of a patient with ceap 6 disease were treated.The procedure was described as uneventful.The patient returned approx.2 weeks post procedure with multiple large painless blisters and erythema along the treated gsv & ssv.The patient was treated with anti-inflammatories and antibiotics.All blister eventually burst and exuded white substance over a 6-12 month period.A 12 month scan showed that both the gsv and ssv remained ablated.
 
Manufacturer Narrative
The anti-inflammatory was arcoxia.The patients' wound is healed and is reported to be doing well.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8743408
MDR Text Key149492037
Report Number9612164-2019-02575
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/28/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2019
Device Catalogue NumberSP-101
Device Lot Number47678
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/04/2019
Date Device Manufactured06/13/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age42 YR
-
-